Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doug Coyle

Showing results (71-80 of 186) with videos related to

Pageof 19
Sort By:
Genetic Testing|March 1, 2008
The influence of experiential knowledge on prenatal screening and testing decisionsHolly Etchegary, Beth Potter, Heather Howley, et al.
Journal of the American College of Emergency Physicians Open|June 27, 2025
Comparing the Costs Associated with Anxiolytic Agents for Reducing Distress in Children Undergoing Laceration Repair in the Emergency DepartmentNam-Anh Tran, Yi-Shu Lin, Petros Pechlivanoglou, et al.
Infection Control and Hospital Epidemiology|November 24, 2018
The return of investment of hospital-based surgical quality improvement programs in reducing surgical site infection at a Canadian tertiary-care hospitalSasha van Katwyk, Kednapa Thavorn, Doug Coyle, et al.
The Lancet. Neurology|April 16, 2022
Spinal cord stimulation for chronic painMichael C Ferraro, William Gibson, Andrew S C Rice, et al.
Systematic Reviews|March 29, 2019
Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: protocol for a systematic review of economic evaluationsJesse Elliott, Bláthnaid McCoy, Tammy Clifford, et al.
Seizure|May 4, 2020
Neurologists' perspectives on medical cannabis for pediatric drug-resistant epilepsy in Canada: A qualitative interview studyJesse Elliott, Deirdre DeJean, Beth K Potter, et al.
Journal of General Internal Medicine|July 18, 2014
Application of a policy framework for the public funding of drugs for rare diseasesEric Winquist, Doug Coyle, Joe T R Clarke, et al.
International Journal of Technology Assessment in Health Care|November 20, 2023
The role of quantitative bias analysis for nonrandomized comparisons in health technology assessment: recommendations from an expert workshopThomas P Leahy, Isabelle Durand-Zaleski, Laura Sampietro-Colom, et al.
Addiction (Abingdon, England)|January 30, 2018
A utility of model input uncertainty analysis in transferring tobacco control-related economic evidence to countries with scarce resources: results from the EQUIPT studyBertalan Németh, Puttarin Kulchaitanaroaj, Adam Lester-George, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 8, 2020
Stated Preferences for Attributes of a <i>CYP2C19</i> Pharmacogenetic Test Among the General Population Presented with a Hypothetical Acute Coronary Syndrome ScenarioBasil G Bereza, Doug Coyle, Derek Y So, et al.
Pageof 19

Showing results (71-80 of 186) with videos related to

Sort By:
Pageof 19
Genetic Testing|March 1, 2008
The influence of experiential knowledge on prenatal screening and testing decisionsHolly Etchegary, Beth Potter, Heather Howley, et al.
Journal of the American College of Emergency Physicians Open|June 27, 2025
Comparing the Costs Associated with Anxiolytic Agents for Reducing Distress in Children Undergoing Laceration Repair in the Emergency DepartmentNam-Anh Tran, Yi-Shu Lin, Petros Pechlivanoglou, et al.
Infection Control and Hospital Epidemiology|November 24, 2018
The return of investment of hospital-based surgical quality improvement programs in reducing surgical site infection at a Canadian tertiary-care hospitalSasha van Katwyk, Kednapa Thavorn, Doug Coyle, et al.
The Lancet. Neurology|April 16, 2022
Spinal cord stimulation for chronic painMichael C Ferraro, William Gibson, Andrew S C Rice, et al.
Systematic Reviews|March 29, 2019
Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: protocol for a systematic review of economic evaluationsJesse Elliott, Bláthnaid McCoy, Tammy Clifford, et al.
Seizure|May 4, 2020
Neurologists' perspectives on medical cannabis for pediatric drug-resistant epilepsy in Canada: A qualitative interview studyJesse Elliott, Deirdre DeJean, Beth K Potter, et al.
Journal of General Internal Medicine|July 18, 2014
Application of a policy framework for the public funding of drugs for rare diseasesEric Winquist, Doug Coyle, Joe T R Clarke, et al.
International Journal of Technology Assessment in Health Care|November 20, 2023
The role of quantitative bias analysis for nonrandomized comparisons in health technology assessment: recommendations from an expert workshopThomas P Leahy, Isabelle Durand-Zaleski, Laura Sampietro-Colom, et al.
Addiction (Abingdon, England)|January 30, 2018
A utility of model input uncertainty analysis in transferring tobacco control-related economic evidence to countries with scarce resources: results from the EQUIPT studyBertalan Németh, Puttarin Kulchaitanaroaj, Adam Lester-George, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 8, 2020
Stated Preferences for Attributes of a <i>CYP2C19</i> Pharmacogenetic Test Among the General Population Presented with a Hypothetical Acute Coronary Syndrome ScenarioBasil G Bereza, Doug Coyle, Derek Y So, et al.
Pageof 19